PLC-β-IN-1
Based on 1 publication(s) in Google Scholar
PLC-β-IN-1 (Compound 8a) is a PLCβ inhibitor. PLC-β-IN-1 exerts anti-airway contraction activity by inhibiting PLCβ and its downstream signaling pathways, and can enhance the airway relaxation effect of β-agonists. PLC-β-IN-1 can be used in the study of asthma.
For research use only. We do not sell to patients.
- Formula: C18H21F3O3
- Molecular Weight:342.35
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) PLC-β-IN-1
MoreAll Phospholipase Isoforms
More
Biological Activity
Chemical Information
-
Molecular Weight 342.35
-
Formula C18H21F3O3
-
SMILES
O=C(/C=C/CCCCC)/C=C/C1=CC(C(F)(F)F)=C(O)C(CO)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Cell Death Differ
A neutrophil-intrinsic CKLF1-PKM2 axis drives glycolytic flux for de novo DAG synthesis and pro-inflammatory ROS production. [Abstract]2026 May 12. PMID: 42120940
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
PLC-β-IN-1 Related Classifications
HY-176525 Related Classifications
Powered by Bioz